210 related articles for article (PubMed ID: 37918086)
1. Human umbilical cord mesenchymal stem cells inhibit liver fibrosis via the microRNA-148a-5p/SLIT3 axis.
Yuan M; Yao L; Chen P; Wang Z; Liu P; Xiong Z; Hu X; Li L; Jiang Y
Int Immunopharmacol; 2023 Dec; 125(Pt A):111134. PubMed ID: 37918086
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stem cells improve liver fibrosis and protect hepatocytes by promoting microRNA-148a-5p-mediated inhibition of Notch signaling pathway.
Zhou Q; Rong C; Gu T; Li H; Wu L; Zhuansun X; Zhao X; Xiao Z; Kuang Y; Xu S; Wang S
Stem Cell Res Ther; 2022 Jul; 13(1):354. PubMed ID: 35883205
[TBL] [Abstract][Full Text] [Related]
3. Human umbilical cord-derived mesenchymal stromal cells alleviate liver cirrhosis through the Hippo/YAP/Id1 pathway and macrophage-dependent mechanism.
Yao L; Hu X; Yuan M; Liu P; Zhang Q; Wang Z; Chen P; Xiong Z; Wu L; Dai K; Jiang Y
Int Immunopharmacol; 2023 Oct; 123():110456. PubMed ID: 37494836
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stem cell-derived exosomes protect against liver fibrosis via delivering miR-148a to target KLF6/STAT3 pathway in macrophages.
Tian S; Zhou X; Zhang M; Cui L; Li B; Liu Y; Su R; Sun K; Hu Y; Yang F; Xuan G; Ma S; Zheng X; Zhou X; Guo C; Shang Y; Wang J; Han Y
Stem Cell Res Ther; 2022 Jul; 13(1):330. PubMed ID: 35858897
[TBL] [Abstract][Full Text] [Related]
5. Human Umbilical Cord Mesenchymal Stem Cells Ameliorate Hepatic Stellate Cell Activation and Liver Fibrosis by Upregulating MicroRNA-455-3p through Suppression of p21-Activated Kinase-2.
Zhou Q; Gu T; Zhang Y; Li H; Zhuansun X; Xu S; Kuang Y
Biomed Res Int; 2021; 2021():6685605. PubMed ID: 33708992
[TBL] [Abstract][Full Text] [Related]
6. sEVs from tonsil-derived mesenchymal stromal cells alleviate activation of hepatic stellate cells and liver fibrosis through miR-486-5p.
Kim J; Lee C; Shin Y; Wang S; Han J; Kim M; Kim JM; Shin SC; Lee BJ; Kim TJ; Jung Y
Mol Ther; 2021 Apr; 29(4):1471-1486. PubMed ID: 33348053
[TBL] [Abstract][Full Text] [Related]
7. Human umbilical cord-mesenchymal stem cells-derived exosomes carrying microRNA-15a-5p possess therapeutic effects on Wilms tumor via regulating septin 2.
Huang H; Zhong P; Zhang J; Chen X; Chen J; Lin T; Wu Q
Bioengineered; 2022 Mar; 13(3):6136-6149. PubMed ID: 35200105
[TBL] [Abstract][Full Text] [Related]
8. Human umbilical cord mesenchymal stem cell-derived exosomes carrying miR-1827 downregulate SUCNR1 to inhibit macrophage M2 polarization and prevent colorectal liver metastasis.
Chen J; Li Z; Yue C; Ma J; Cao L; Lin J; Zhu D; An R; Lai J; Guo Y; Gu B
Apoptosis; 2023 Apr; 28(3-4):549-565. PubMed ID: 36652132
[TBL] [Abstract][Full Text] [Related]
9. Enhanced expression of hepatocyte-specific microRNAs in valproic acid mediated hepatic trans-differentiation of human umbilical cord derived mesenchymal stem cells.
Raut A; Khanna A
Exp Cell Res; 2016 May; 343(2):237-247. PubMed ID: 27001466
[TBL] [Abstract][Full Text] [Related]
10. Human umbilical cord-derived mesenchymal stem cell-exosomal miR-627-5p ameliorates non-alcoholic fatty liver disease by repressing FTO expression.
Cheng L; Yu P; Li F; Jiang X; Jiao X; Shen Y; Lai X
Hum Cell; 2021 Nov; 34(6):1697-1708. PubMed ID: 34410623
[TBL] [Abstract][Full Text] [Related]
11. Human umbilical cord-derived mesenchymal stem cells attenuate hepatic stellate cells activation and liver fibrosis.
Shi X; Zhang K; Qi Q; Zhou W; Yu F; Zhang Y
Mol Biol Rep; 2024 Jun; 51(1):734. PubMed ID: 38874773
[TBL] [Abstract][Full Text] [Related]
12. Human umbilical cord-derived mesenchymal stromal cells improve myocardial fibrosis and restore miRNA-133a expression in diabetic cardiomyopathy.
Liu B; Wei Y; He J; Feng B; Chen Y; Guo R; Griffin MD; Hynes SO; Shen S; Liu Y; Cui H; Ma J; O'Brien T
Stem Cell Res Ther; 2024 Apr; 15(1):120. PubMed ID: 38659015
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of human umbilical cord mesenchymal stem cells-derived exosomal lncRNA GAS5 in alleviating EMT of HPMCs via Wnt/β-catenin signaling pathway.
Huang Y; Ma J; Fan Y; Yang L
Aging (Albany NY); 2023 May; 15(10):4144-4158. PubMed ID: 37229651
[TBL] [Abstract][Full Text] [Related]
14. MSC-Derived Small Extracellular Vesicles Attenuate Autoimmune Dacryoadenitis by Promoting M2 Macrophage Polarization and Inducing Tregs
Li N; Gao Z; Zhao L; Du B; Ma B; Nian H; Wei R
Front Immunol; 2022; 13():888949. PubMed ID: 35874782
[TBL] [Abstract][Full Text] [Related]
15. Exosomes derived from human umbilical cord mesenchymal stem cells ameliorate IL-6-induced acute liver injury through miR-455-3p.
Shao M; Xu Q; Wu Z; Chen Y; Shu Y; Cao X; Chen M; Zhang B; Zhou Y; Yao R; Shi Y; Bu H
Stem Cell Res Ther; 2020 Jan; 11(1):37. PubMed ID: 31973730
[TBL] [Abstract][Full Text] [Related]
16.
Zhang GZ; Sun HC; Zheng LB; Guo JB; Zhang XL
World J Gastroenterol; 2017 Dec; 23(46):8152-8168. PubMed ID: 29290652
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow mesenchymal stem cells inhibit hepatic fibrosis via the AABR07028795.2/rno-miR-667-5p axis.
Feng Y; Li Y; Xu M; Meng H; Dai C; Yao Z; Lin N
Stem Cell Res Ther; 2022 Jul; 13(1):375. PubMed ID: 35902883
[TBL] [Abstract][Full Text] [Related]
18. Extracellular Vesicles from miR-148a-5p-Enriched Bone Marrow Mesenchymal Stem Cells Relieve Hepatic Fibrosis by Targeting Smad4.
Xuan J; Xu H; Li H; Chen D; Qiu Y; Chen X; Shao M; Xia X
Mol Biotechnol; 2022 May; 64(5):535-545. PubMed ID: 35006577
[TBL] [Abstract][Full Text] [Related]
19. Anti-TGFβ-1 receptor inhibitor mediates the efficacy of the human umbilical cord mesenchymal stem cells against liver fibrosis through TGFβ-1/Smad pathway.
Xuan J; Feng W; An ZT; Yang J; Xu HB; Li J; Zhao ZF; Wen W
Mol Cell Biochem; 2017 May; 429(1-2):113-122. PubMed ID: 28181132
[TBL] [Abstract][Full Text] [Related]
20. Human umbilical cord-derived mesenchymal stem cells ameliorate liver fibrosis by improving mitochondrial function via Slc25a47-Sirt3 signaling pathway.
Chen P; Yuan M; Yao L; Xiong Z; Liu P; Wang Z; Jiang Y; Li L
Biomed Pharmacother; 2024 Feb; 171():116133. PubMed ID: 38198960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
